|
🐜
|
Complementary Signaling Pathways Regulate the Unfolded Protein Response and Are Required for C. elegans Development
11 auth.
Xiaohua Shen,
R. Ellis,
Kyungho Lee,
Chuan-Yin Liu,
Kun Yang,
A. Solomon,
...
H. Yoshida,
Rick Morimoto,
D. Kurnit,
K. Mori,
R. Kaufman
|
9 |
2001 |
9
🐜
|
|
🐜
|
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.
19 auth.
Bhavna Kumar,
K. Cordell,
J. Lee,
F. Worden,
M. Prince,
H. Tran,
G. Wolf,
S. Urba,
D. Chepeha,
T. Teknos,
...
A. Eisbruch,
C. Tsien,
Jeremy M. G. Taylor,
N. D’Silva,
Kun Yang,
D. Kurnit,
Joshua A. Bauer,
C. Bradford,
T. Carey
|
9 |
2008 |
9
🐜
|
|
🐜
|
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
12 auth.
Ines A. Silva,
Shoumei Bai,
K. McLean,
Kun Yang,
K. Griffith,
Dafydd G. Thomas,
...
C. Ginestier,
C. Johnston,
Angela S. Kueck,
R. Reynolds,
M. Wicha,
R. Buckanovich
|
8 |
2011 |
8
🐜
|
|
🐜
|
Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.
20 auth.
F. Worden,
Bhavna Kumar,
J. Lee,
G. Wolf,
K. Cordell,
Jeremy M. G. Taylor,
S. Urba,
A. Eisbruch,
T. Teknos,
D. Chepeha,
...
M. Prince,
C. Tsien,
N. D’Silva,
Kun Yang,
D. Kurnit,
H. Mason,
Tamara H. Miller,
Nancy E. Wallace,
C. Bradford,
T. Carey
|
8 |
2008 |
8
🐜
|
|
🐜
|
Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.
11 auth.
K. McLean,
Y. Gong,
Yun-Jung Choi,
Ning Deng,
Kun Yang,
Shoumei Bai,
...
L. Cabrera,
E. Keller,
L. McCauley,
Kathleen R. Cho,
R. Buckanovich
|
8 |
2011 |
8
🐜
|
|
🐜
|
Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations
32 auth.
G. Vogt,
A. Chapgier,
Kun Yang,
N. Chuzhanova,
J. Feinberg,
C. Fieschi,
S. Boisson-Dupuis,
A. Alcais,
O. Filipe-santos,
J. Bustamante,
L. Beaucoudrey,
I. Al-Mohsen,
Sami Al-Hajjar,
A. Al-ghonaium,
P. Adimi,
...
M. Mirsaeidi,
S. Khalilzadeh,
S. Rosenzweig,
O. D. L. C. Martín,
T. R. Bauer,
J. Puck,
H. Ochs,
D. Furthner,
C. Engelhorn,
B. Belohradsky,
D. Mansouri,
S. Holland,
R. Schreiber,
L. Abel,
D. Cooper,
C. Soudais,
J. Casanova
|
7 |
2005 |
7
🐜
|
|
🐜
|
Metformin targets ovarian cancer stem cells in vitro and in vivo.
7 auth.
J. Shank,
Kun Yang,
J. Ghannam,
L. Cabrera,
C. Johnston,
R. Reynolds,
...
R. Buckanovich
|
7 |
2012 |
7
🐜
|
|
🐜
|
Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking.
18 auth.
Bhavna Kumar,
K. Cordell,
J. Lee,
M. Prince,
H. Tran,
G. Wolf,
S. Urba,
F. Worden,
D. Chepeha,
T. Teknos,
...
A. Eisbruch,
C. Tsien,
Jeremy M. G. Taylor,
N. D’Silva,
Kun Yang,
D. Kurnit,
C. Bradford,
T. Carey
|
6 |
2007 |
6
🐜
|
|
🐜
|
A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells.
26 auth.
Ilana Chefetz,
E. Grimley,
Kun Yang,
Linda J Hong,
E. Vinogradova,
R. Suciu,
I. Kovalenko,
D. Karnak,
C. Morgan,
Mikhail Chtcherbinine,
C. Buchman,
Brandt C. Huddle,
Scott J. Barraza,
M. Morgan,
Kara A. Bernstein,
...
E. Yoon,
D. Lombard,
A. Bild,
G. Mehta,
Iris L. Romero,
Chun-Yi Chiang,
C. Landen,
B. Cravatt,
T. Hurley,
S. Larsen,
R. Buckanovich
|
6 |
2019 |
6
🐜
|
|
🐬
|
VEGFR3 inhibition chemosensitizes ovarian cancer stemlike cells through down-regulation of BRCA1 and BRCA2.
Jae-Jun Lim,
Kun Yang,
Barbie Taylor-Harding,
W. Wiedemeyer,
R. Buckanovich
|
6 |
2014 |
6
🐬
|
|
🐬
|
Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma
Linli Zhou,
Kun Yang,
T. Andl,
R. R. Wickett,
Yuhang Zhang
|
6 |
2015 |
6
🐬
|
